Heather Raymon
Corporate Officer/Principal presso Artiva Biotherapeutics, Inc.
Posizioni attive di Heather Raymon
Società | Posizione | Inizio | Fine |
---|---|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/10/2020 | - |
Storia della carriera di Heather Raymon
Precedenti posizioni note di Heather Raymon
Società | Posizione | Inizio | Fine |
---|---|---|---|
CELGENE | Corporate Officer/Principal | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
Formazione di Heather Raymon
State University of New York at Albany | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Heather Raymon
- Esperienza